Hospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: Potential antitumour dual agents

    MedChemComm, Vol. 10, Núm. 9, pp. 1589-1598